The association between combination antiretroviral adherence and AIDS-defining conditions at HIV diagnosis

References

• Abara, W., & Heiman, H. J. (2014). The affordable care act and low-income people living with HIV: Looking forward in 2014 and beyond. Journal of the Association of Nurses in AIDS Care, 25(6), 476–482. doi: 10.1016/j.jana.2014.05.002
   PubMed Web of Science ®Google Scholar
• Battegay, M., Nüesch, R., Hirschel, B., & Kaufmann, G. R. (2006). Immunological recovery and antiretroviral therapy in HIV-1 infection. The Lancet Infectious Diseases, 6(5), 280–287. doi: 10.1016/S1473-3099(06)70463-7
   PubMed Web of Science ®Google Scholar
• Brooks, J. T., Kaplan, J. E., Holmes, K. K., Benson, C., Pau, A., & Masur, H. (2009). HIV-associated opportunistic infections – going, going, but not gone: The continued need for prevention and treatment guidelines. Clinical Infectious Diseases, 48(5), 609–611. doi: 10.1086/596756
   PubMed Web of Science ®Google Scholar
• Cahill, S. R., Mayer, K. H., & Boswell, S. L. (2015). The Ryan White HIV/AIDS program in the age of health care reform. American Journal of Public Health, 105(6), 1078–1085. doi: 10.2105/AJPH.2014.302442
   PubMed Web of Science ®Google Scholar
• Cohen, C. J., Meyers, J. L., & Davis, K. L. (2013). Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US Medicaid population with HIV. BMJ Open, 3(8), e003028-1–12. doi: 10.1136/bmjopen-2013-003028
   Google Scholar
• Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … Fleming, T. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365(6), 493–505. doi: 10.1056/NEJMoa1105243
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services. (2008, November 3). Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (pp. 1–139). Retrieved May 10, 2015, from http://aidsinfo.nih.gov/contentfiles/adultandadolescentgl001226.pdf
   Google Scholar
• DiMatteo, M. R., Haskard, K. B., & Williams, S. L. (2007). Health beliefs, disease severity, and patient adherence: A meta-analysis. Medical Care, 45(6), 521–528. doi: 10.1097/MLR.0b013e318032937e
   PubMed Web of Science ®Google Scholar
• Fielden, S. J., Rusch, M. L., Yip, B., Wood, E., Shannon, K., Levy, A. R., … Hogg, R. S. (2008). Non-adherence increases the risk of hospitalization among HIV-infected antiretroviral naive patients started on HAART. Journal of the International Association of Physicians in AIDS Care (JIAPAC), 7(5), 238–244. doi: 10.1177/1545109708323132
   PubMedGoogle Scholar
• Gao, X., Nau, D. P., Rosenbluth, S. A., Scott, V., & Woodward, C. (2000). The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care, 12(4), 387–398. doi: 10.1080/09540120050123783
   PubMed Web of Science ®Google Scholar
• Gonzalez, J. S., Penedo, F. J., Llabre, M. M., Durán, R. E., Antoni, M. H., Schneiderman, N., & Horne, R. (2007). Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence. Annals of Behavioral Medicine, 34(1), 46–55. doi: 10.1007/BF02879920
   PubMed Web of Science ®Google Scholar
• Hanna, D. B., Gupta, L. S., Jones, L. E., Thompson, D. M., Kellerman, S. E., & Sackoff, J. E. (2007). AIDS-defining opportunistic illnesses in the HAART era in New York City. AIDS Care, 19(2), 264–272. doi: 10.1080/09540120600834729
   PubMed Web of Science ®Google Scholar
• Higa, D. H., Marks, G., Crepaz, N., Liau, A., & Lyles, C. M. (2012). Interventions to improve retention in HIV primary care: A systematic review of US studies. Current HIV/AIDS Reports, 9(4), 313–325. doi: 10.1007/s11904-012-0136-6
   PubMed Web of Science ®Google Scholar
• Horvath, T., Azman, H., Kennedy, G. E., & Rutherford, G. W. (2012). Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. Cochrane Database of Systematic Reviews, 3, doi.10.1002/14651858.CD009756.
   Google Scholar
• Ingersoll, K. S., & Cohen, J. (2008). The impact of medication regimen factors on adherence to chronic treatment: A review of literature. Journal of Behavioral Medicine, 31(3), 213–224. doi: 10.1007/s10865-007-9147-y
   PubMed Web of Science ®Google Scholar
• Lewden, C., Chêne, G., Morlat, P., Raffi, F., Dupon, M., Dellamonica, P., … Leport, C. (2007). HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. Journal of Acquired Immune Deficiency Syndromes, 46(1), 72–77.
   PubMed Web of Science ®Google Scholar
• Morbidity and Mortality Weekly Report. (2008, December 5). AIDS-defining conditions. 57(RR10), 9. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5710a2.htm
   Google Scholar
• O'Neil, C. R., Palmer, A. K., Coulter, S., O'Brien, N., Shen, A., Zhang, W., … Hogg, R. S. (2012). Factors associated with antiretroviral medication adherence among HIV-positive adults accessing highly active antiretroviral therapy (HAART) in British Columbia, Canada. Journal of the International Association of Physicians in AIDS Care (JIAPAC). doi:10.1177/1545109711423976
   PubMedGoogle Scholar
• Palella Jr, F. J., Baker, R. K., Moorman, A. C., Chmiel, J. S., Wood, K. C., Brooks, J. T., … Holmberg, S. (2006). Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study. Journal of Acquired Immune Deficiency Syndromes, 43(1), 27–34. doi: 10.1097/01.qai.0000233310.90484.16
   PubMed Web of Science ®Google Scholar
• Puskas, C. M., Forrest, J. I., Parashar, S., Salters, K. A., Cescon, A. M., Kaida, A., … Hogg, R. S. (2011). Women and vulnerability to HAART non-adherence: A literature review of treatment adherence by gender from 2000 to 2011. Current HIV/AIDS Reports, 8(4), 277–287. doi: 10.1007/s11904-011-0098-0
   PubMedGoogle Scholar
• Sackoff, J.E., Hanna, D.B., Pfeiffer, M.R., & Torian, L.V. (2006). Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Annals of Internal Medicine, 145(6), 397–406.
   Google Scholar
• Shelton, R. C., Golin, C. E., Smith, S. R., Eng, E., & Kaplan, A. (2006). Role of the HIV/AIDS case manager: Analysis of a case management adherence training and coordination program in North Carolina. AIDS Patient Care STDs, 20(3), 193–204. doi: 10.1089/apc.2006.20.193
   PubMed Web of Science ®Google Scholar
• Simoni, J. M., Huh, D., Wilson, I. B., Shen, J., Goggin, K., Reynolds, N. R., … Liu, H. (2012). Racial/ethnic disparities in ART adherence in the United States: Findings from the MACH14 study. Journal of Acquired Immune Deficiency Syndromes, 60(5), 466–472. doi: 10.1097/QAI.0b013e31825db0bd
   PubMed Web of Science ®Google Scholar
• Singh, N. I. N. A., Squier, C., Sivek, C., Wagener, M., Nguyen, M. H., & Yu, V. L. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care, 8(3), 261–270. doi: 10.1080/09540129650125696
   PubMed Web of Science ®Google Scholar